Percheron Therapeutics LimitedASX: PER

Vanderbilt Health to conduct clinical trial of HMBD-002

· Issued by Percheron Therapeutics Limited

Percheron Therapeutics Limited has released a press release.

View Attachment

Earlier from Percheron Therapeutics

All Percheron Therapeutics news releases